期刊文献+

日本药品价格管理启示 被引量:19

Impression of Japanese experience to Chinese drug pricing regulation
下载PDF
导出
摘要 研究日本的药品价格管理模式,为我国的药品价格管理政策制定、政府部门决策提供参考。通过文献研究及比较,阐述日本药品价格管理政策,并对其进行评价,最后提出日本做法对我国药品价格管理政策的启示,并针对我国国情提出建议。日本的药品价格管理成果显著,尤其在新药定价、创新药评价、市场价格调查、仿制药定价等方面有较为科学的定价流程及依据,而且在定价方法中融入了药物经济学思想,值得我国借鉴。 In this review, we described the Japanese drug pricing model to make reference to the drug price administration and government decision in our country. We studied literature and made comparison to introduce and evaluate the Japanese drug pricing model. Through comparing the drug price administration policy in China and Japan, we put forward opinions and proposals for the improvement of the relevant policy. Japanese drug price administration has made remarkable results, particularly in the new drug pricing process, novel drug evaluating, market price survey, and generic drug pricing. Especially, the new drug pricing method evolves the pharmacoeconomics thoughts. It deserves our reference.
作者 刘昕 史录文
出处 《中国新药杂志》 CAS CSCD 北大核心 2008年第23期1993-1995,2002,共4页 Chinese Journal of New Drugs
关键词 日本 药品价格 管理模式 Japan drug price administration model
  • 相关文献

参考文献4

  • 1卫生部.卫生部关于日本药品价格管理和药品采购的考察报告[EB/OL].[2008-04-15]http://www.pharmnet.com.cn/conf/gjdt/aetion.cgi?f=page_1_&t=page_1_&id=68084.
  • 2中国社会保险学会医疗保险分会.关于韩国、日本医疗保险制度改革情况及药品管理的考察报告[EB/OL].[2008-04-15]http://www.mib.com.cn/preview/cnmib/disserlation/ggkkbg/index.htm.
  • 3药业研究会.药价基准保险药事典[M].东京:药业时报社,平成10,8.
  • 4杨莉,胡善联,宫印成.药物经济学评价在卫生决策中的国际应用[J].中国药房,2004,15(6):347-350. 被引量:34

二级参考文献18

  • 1陈英耀.OECD国家卫生费用和卫生服务的趋势[J].中国卫生资源,2001,4(3):141-144. 被引量:10
  • 2Drummond,MF.The role of economic evaluation in the pricing and reimbursement of medicines[J] .Health Policy, 1997,40:199.
  • 3Ministry of health, welfare and sports. The Future of Health Insurance System [ S ]. Dutch, 1999.
  • 4Ziekenfondsraad.Dutch Guidelines for Pharmacoeconomic Research [ S]. Ziekenfondsraad amst elveen, March,1999.
  • 5Tobin H,Tumer N,Wyatt G.Pharmacoeconomics 2002:A Concise Guide [ S ]. PPR Communications, Ltd., Cambridge, UK. 2002.
  • 6Torrance G.Current experience with guidelines for economic evaluation in Canada[J ]. Drug Information Journal, 1996,30: 507.
  • 7Glennie JL,Torrance GW,Baladi JF,et al .The revised Canadian guidelines for the economic evaluation of pharmaceuticals [ J ] . Pharmacoeconom ics, 1999,15(5): 459.
  • 8Anis AH,Gagnon Y.Using economic evaluations to make formulary coverage decisions: so much for guidelines[J]. Pharmacoeconomics, 2000,18(1): 55.
  • 9Kanavos P.Pharmaceutical Pricing and Reimbursement in Europe- 2002[ S ].PJB Publications Ltd. 2002.
  • 10National Institute for Clinical Excellence. Technical Guidance for Manufacturers and Sponsors on Making a Submission to a Technology Appraisal [S] .March,2001

共引文献34

同被引文献177

引证文献19

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部